Korean Fat Dissolving Injections: PPC vs DC Product Guide for Clinics

Q: What is the difference between PPC and deoxycholic acid?

DC is generally the principal membrane-disrupting component. PPC's independent clinical contribution remains less clearly defined in published research. Some products use DC alone, others combine with PPC.

Q: Is Kabelline the same as Kybella?

Both use deoxycholic acid. Kybella is the US FDA-approved version by Allergan. Kabelline is a Korean-manufactured alternative widely used internationally. Same active-ingredient category, separate products from different manufacturers.

Q: Which fat dissolving injection causes the least swelling?

Enzyme-based products like Pine Bottle are marketed as lower swelling, but limited independent clinical evidence is available. DC-based products commonly cause moderate swelling for several days.

Q: How many sessions are needed?

Varies by product, area and patient. Kybella FDA label specifies up to 6 treatments for submental fat. Korean products generally recommend 2-5 sessions. Follow each product's IFU.

Korean Fat Dissolving Injections: What Clinics Need to Know Before Stocking Any Product

Written by FillersFairy Editorial · Reviewed by FillersFairy Clinical Team · Last updated: June 21, 2026

Quick Answer

Products marketed as fat dissolving injections use different ingredients and do not all share the same mechanism or level of clinical evidence. Deoxycholic acid (the active ingredient in Kybella) has the most extensive clinical trial history. Korean-manufactured alternatives — including Lipo Lab, Kabelline, Lipovela and Dr. Lipo+ — are distributed internationally and offer competitive wholesale pricing with a range of formulation approaches. For clinic buyers, the procurement decision involves understanding the differences in active ingredients, evidence base, regulatory status in your specific market, and manufacturer documentation.

What “Fat Dissolving Injection” Actually Means

Injectable lipolysis refers to the subcutaneous injection of solutions that are intended to reduce localised fat deposits. The best-documented mechanism involves deoxycholic acid (a bile acid naturally present in the human body), which destroys fat cell membranes through cytolysis. The treated fat cells are then processed and eliminated by the body’s metabolic pathways over several weeks.

These treatments target localised fat — submental fullness (double chin), small body deposits resistant to diet and exercise. They are not weight-loss solutions and are not appropriate for patients seeking overall fat reduction.

Regulatory Landscape

Injectable lipolysis products have different regulatory classifications depending on the country. In the US, Kybella (deoxycholic acid by Allergan) is the FDA-approved option for submental fat. Korean alternatives are widely used internationally through local regulatory pathways in Asia, Europe, the Middle East and Latin America. Product availability and practitioner scope vary by jurisdiction — clinics should confirm local requirements when adding any new injectable to their menu.

DC vs PPC/DC vs Enzyme Formulations — What the Evidence Supports

Products in this category use three broadly different formulation approaches. Their evidence bases are not equivalent:

Formulation Type	Key Ingredient(s)	How It Works	Clinical Profile
Deoxycholic acid (DC)	Synthetic deoxycholic acid	Directly disrupts adipocyte membranes through cytolysis. The body’s lymphatic system processes and eliminates the released lipids.	Most extensively studied active ingredient in injectable lipolysis. Kybella (DC-based) has completed multiple clinical trials.
PPC + DC combination	Phosphatidylcholine + sodium deoxycholate	Sodium deoxycholate disrupts the fat cell membrane; PPC assists with lipid dispersion and emulsification. Additional ingredients (L-Carnitine, B vitamins) support fat metabolism.	Widely used in mesotherapy protocols since the early 2000s. The combination approach allows for additional skin-supportive ingredients.
Enzyme / vitamin-based	Bromelain, riboflavin, plant extracts	Stimulates metabolic fat breakdown through enzymatic activity rather than chemical membrane disruption. Gentler mechanism produces less tissue inflammation.	Growing adoption in clinics prioritising minimal-downtime treatments. Patients report less swelling compared to DC-based products.

Product Comparison for Clinic Buyers

Product	Manufacturer	Active Ingredients	Pack Size	Marketed Positioning	Market Track Record
Lipo Lab PPC	Medihub (Korea)	PPC + DC (99.8% German-sourced PPC)	10 mL × 10	Body contouring (abdomen, thighs, flanks)	One of the most widely adopted Korean lipolytics globally; room-temp storage
Kabelline	(Korea)	Deoxycholic acid	8 mL × 5	Facial contouring (chin, jawline V-line)	Strong adoption for facial contouring in Asia, Europe and Middle East
Lipovela	(Korea)	PPC + DC + L-Carnitine + B vitamins + growth factors	10 mL × 10	Body contouring + skin quality maintenance	Differentiated by skin-supportive growth factors and antioxidants alongside lipolysis
Dr. Lipo+	BNC Global (Korea)	PPC + DC + peptide complexes	10 mL × 10	Body contouring + cellulite + skin tightening	Gamma-sterilised; 99.8% purity; peptide lifting effect post-lipolysis
Pine Bottle	(Korea)	Bromelain, riboflavin, plant extracts	10 mL × 5	Low-downtime facial contouring	Growing popularity for patients who prioritise minimal swelling and same-day recovery

Note: Lipovela V and Dr. Lipo+ V are face-specific formulations of their respective brands. Lipo Lab V-Line contains PDRN in addition to its lipolytic components.

Face vs Body Product Positioning

From an inventory perspective, the fat dissolving category divides into two use cases with different product requirements:

Facial contouring (chin, jawline, jowls): Requires precision, smaller injection volumes and products specifically formulated or marketed for facial use. DC-based products (Kabelline) and face-specific variants (Lipovela V, Dr. Lipo+ V, Lipo Lab V-Line) are positioned for this application.

Body contouring (abdomen, thighs, flanks, arms): Involves larger treatment areas, higher product volumes per session and products formulated for subcutaneous body fat. PPC + DC combination products (Lipo Lab PPC, Lipovela, Dr. Lipo+) are positioned for this application.

Note: Product positioning reflects the manufacturer’s intended use. Clinics should verify local regulatory requirements and ensure treatments are within their scope of practice.

Procurement Checklist

When evaluating any injectable lipolysis product for your clinic, verify:

☐ Manufacturer name and Certificate of Analysis
☐ Active ingredient names and concentrations per label
☐ MFDS registration number (for Korean products)
☐ CE marking (if applicable to your market)
☐ Manufacturer’s Instructions for Use (IFU)
☐ Storage requirements and shelf life
☐ Batch number and expiry date
☐ Contraindications listed by the manufacturer

Inventory Decision Framework

For clinics building a fat dissolving treatment menu, the procurement decision starts with two questions:

1. What is your regulatory environment? In the US, only Kybella is approved. In other jurisdictions, verify which products are registered locally. Do not assume that a product available for purchase is automatically legal to administer in your country.

2. What treatment areas will you offer? Facial contouring and body contouring require different products, different volumes and different skill sets. Most clinics that offer both maintain at least one face-focused product and one body-focused product.

Minimum viable inventory (non-US clinics where Korean products are permitted):

One face product (Kabelline for DC-based approach, or a face-specific variant like Lipovela V or Dr. Lipo+ V) plus one body product (Lipo Lab PPC, Lipovela or Dr. Lipo+ depending on desired product positioning and patient profile).

Training and Practice Considerations

Treatment parameters — including injection depth, volume, spacing and session intervals — are product-specific. Each product’s IFU provides the manufacturer’s recommended protocol. Practitioners should have appropriate training in injectable lipolysis techniques and relevant anatomy for each treatment area.

Table of Contents

Toggle

Summary for Clinic Buyers

The fat dissolving injection category offers three formulation approaches for different clinical needs: DC-based products for aggressive facial contouring (Kabelline), PPC + DC combinations for versatile body contouring with skin-supportive ingredients (Lipo Lab, Lipovela, Dr. Lipo+), and enzyme-based formulations for minimal-downtime treatments (Pine Bottle). Stocking one face product and one body product covers the majority of patient demand. Korean manufacturers deliver competitive wholesale pricing with established quality controls, making this a high-margin treatment category for clinics building a non-surgical body contouring menu.

Frequently Asked Questions

Are Korean fat dissolving injections safe?

Korean fat dissolving injections from established manufacturers are used by clinics in 60+ countries. As with any injectable procedure, outcomes depend on proper patient selection, correct technique and practitioner training. Products from manufacturers with documented quality controls (gamma sterilisation, pharmaceutical-grade raw materials, MFDS registration) provide a professional-grade option for clinics.

What is the difference between PPC and deoxycholic acid?

Deoxycholic acid (DC) is generally considered the principal membrane-disrupting component in lipolytic formulations. In PPC + DC combination products, DC disrupts the fat cell membrane while PPC has historically been proposed to assist with lipid dispersion. However, the independent clinical contribution of PPC remains less clearly defined in published research (Rotunda et al.). Some products use DC alone; others combine it with PPC and additional ingredients.

Is Kabelline the same as Kybella?

Both use deoxycholic acid as the active ingredient for fat cell disruption. Kybella is the US FDA-approved version by Allergan. Kabelline is a Korean-manufactured alternative widely used for facial contouring in international markets. They share the same active-ingredient category but are separate products from different manufacturers.

Which fat dissolving injection causes the least swelling?

Enzyme/vitamin-based products like Pine Bottle are marketed as producing less swelling than DC-based products. However, limited independent clinical evidence is available to verify these manufacturer claims. DC-based products (including Kybella) commonly cause moderate-to-significant swelling for several days, which is expected as part of the cytolytic mechanism.

How many sessions are needed for fat dissolving injections?

Session counts vary by product, treatment area and individual patient response. Kybella’s FDA label specifies up to six treatments spaced at least one month apart for submental fat. Korean product manufacturers generally recommend 2–5 sessions. Specific protocols should follow each product’s IFU and practitioner clinical judgement.

Related Products

Disclosure: FillersFairy is a wholesale supplier of the Korean products discussed in this article. This guide is for educational and procurement-decision purposes only and does not constitute medical advice. Product regulatory status varies by country; clinics should confirm local requirements.

References

Kybella (deoxycholic acid) prescribing information. FDA label. accessdata.fda.gov.
Rotunda AM, et al. “Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine/sodium deoxycholate formulation used for localized fat dissolution.” Dermatol Surg. 2004;30(7):1001-8. PubMed 18053049.